ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 76 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $169,000 | -91.9% | 23,237 | -95.2% | 0.00% | -94.1% |
| Q4 2020 | $2,096,000 | +16.4% | 485,197 | +10.8% | 0.03% | -8.1% |
| Q3 2020 | $1,801,000 | -31.5% | 438,094 | 0.0% | 0.04% | -42.2% |
| Q2 2020 | $2,629,000 | -75.8% | 438,094 | -69.6% | 0.06% | -82.3% |
| Q1 2020 | $10,849,000 | -46.5% | 1,440,744 | -2.2% | 0.36% | -32.8% |
| Q4 2019 | $20,265,000 | +16.8% | 1,473,824 | +0.9% | 0.54% | -4.6% |
| Q3 2019 | $17,357,000 | -13.2% | 1,461,051 | +2.2% | 0.56% | -9.9% |
| Q2 2019 | $19,997,000 | +29.1% | 1,429,371 | +65.0% | 0.63% | +7.9% |
| Q1 2019 | $15,487,000 | +14.9% | 866,141 | +1.1% | 0.58% | +0.7% |
| Q4 2018 | $13,480,000 | – | 856,976 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |